Dopamine agonist vs levodopa
Number of participants reporting an adverse event · patients with restless legs syndrome
Summary of findings: dopamine agonists showed no clear difference in number of patients experiencing adverse events compared with levodopa (moderate certainty).
1 finding from 1 review
- Dopamine agonists for the treatment of restless legs syndrome 2011 · Cochrane Headline outcomes onlyOR 2.87 [0.43, 19]3 studies · 461 participantsModerate